In contrast to normal tissue or benign lesions, there is a loss of SSTR2 gene expression in pancreatic carcinoma and advanced colorectal cancer and their respective metastases (26,31–33). This evidence concerns the gene SSTR2 and exocrine pancreatic carcinoma.